BriaCell Therapeutics (BCTXW) Short Interest Ratio & Short Volume

Short interest is the volume of BriaCell Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 14,100 shares of BCTXW short. Learn More on BriaCell Therapeutics' current short interest.

BriaCell Therapeutics saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 14,100 shares, an increase of 422.2% from the previous total of 2,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BriaCell Therapeutics: Alvotech (0.07%), Mainz Biomed (9.74%), Pharvaris (0.73%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

Short selling BCTXW is an investing strategy that aims to generate trading profit from BriaCell Therapeutics as its price is falling. BCTXW shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BriaCell Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTXW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTXW, twice per month. The most recent reporting period available is October, 15 2024.